DTPa

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline, Billy W. Loo Jr.

Conditions

Acellular PertussisDiphtheriaDiphtheria-Tetanus-acellular Pertussis VaccinesInfections, StreptococcalLung CancerTetanus

Early Phase 1

4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy

TerminatedNCT01034514

Billy W. Loo Jr.Lung Cancer

Start: 2009-12-31End: 2014-06-24Updated: 2017-05-08

Phase 3

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

CompletedNCT00290342

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus

Start: 2006-01-01End: 2007-01-23Updated: 2018-10-29

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children

CompletedNCT01027845

GlaxoSmithKlineInfections, Streptococcal

Start: 2009-12-08End: 2011-09-17Updated: 2019-11-29

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women

Not yet recruitingNCT07596199

GlaxoSmithKlineDiphtheria-Tetanus-acellular Pertussis Vaccines

Start: 2026-06-29End: 2027-01-20Target: 95Updated: 2026-05-19

Related Papers

Immunogenicity and safety of the 10-valent pneumococcal nontypeable<i>Haemophilus influenzae</i>protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study

Human Vaccines & Immunotherapeutics2015-04-016 citations